Please Wait
Applying Filters...
menu
    • menu
    Top news of 2025: Drugmakers invest in US capacities, agree to lower Medicaid prices; Pfizer buys obesity-focused biotech Metsera

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Gamithromycin

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Holder VMF No. Subject Received Date Status Type
    30/12/2025 Amicogen China Biopharm Co. - Ltd
    China
    		 AMICOGEN CHINA BIOPHARM CO LTD 6474 Gamithromycin 2022-06-07 Active II
    30/12/2025 Marea Therapeutics
    U.S.A
    		 QILU SYNVA PHARMACEUTICAL CO LTD 6519 Gamithromycin 2023-04-23 Active II
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.